Comparative study on the cardioprotective effects against ischemia/reperfusion injury of the selective SGLT2 inhibitors, empagliflozin, dapagliflozin and ertugliflozin in non-diabetic mice

Mylonas, N ; Nikolaou, P.-E ; Efentakis, P ; Dimitriadis, G ; Iliodromitis, E K ; Andreadou, I

Texto completo disponível

Empagliflozin rescues primary murine cardiac fibroblasts, but not cardiomyocytes, from hypoxia-reoxygenation injury through STAT3-mediated cascades

Mylonas, N ; Efentakis, P ; Nikolaou, P E ; Zerikiotis, S ; Pieper, M P ; Dimitriadis, G ; Iliodromitis, E K ; Andreadou, I

Texto completo disponível

The combination of dulaglutide and dapagliflozin improves arterial stiffness, endothelial glycocalyx and albuminuria vs DPP-4 inhibitors independently of glycemic control

Korakas, E ; Ikonomidis, I ; Thymis, J ; Kountouri, A ; Katogiannis, K ; Benas, D ; Prentza, V ; Balampanis, K ; Pliouta, L ; Kousathana, F ; Kostelli, G ; Dimitriadis, G ; Raptis, A ; Lambadiari, V

Texto completo disponível

Effects of epicardial adipose tissue volume and thickness assessed by computed tomography and echocardiography on cardiovascular and cerebrovascular outcomes: a systematic review and meta-analysis

Chong, B ; Jayabaskaran, J ; Ruban, J ; Goh, R ; Chin, Y H ; Kong, G ; Ng, C H ; Foo, R ; Chai, P ; Kong, W ; Poh, K K ; Chan, M Y ; Mehta, A ; Dimitriadis, G K ; Chew, N W S

Texto completo disponível

Higher risk of adverse cardiovascular outcomes in women with type 2 diabetes mellitus: an umbrella review of systematic reviews

Chong, B ; Yaow, C ; Chin, Y H ; Ng, C H ; Goh, R ; Kong, G ; Muthiah, M ; Sukmawati, I ; Lukito, A A ; Chan, M Y ; Khoo, C M ; Mehta, A ; Dimitriadis, G K ; Chew, N W S

Texto completo disponível

Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

Nikolaou, P E ; Mylonas, N ; Makridakis, M ; Makrecka-Kuka, M ; Iliou, A ; Zerikiotis, S ; Efentakis, P ; Kostomitsopoulos, N ; Vilskersts, R ; Zuurbier, C ; Latosinska, A ; Vlahou, A ; Dimitriadis, G ; Iliodromitis, E K ; Andreadou, I

Texto completo disponível

P4461Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus

Abu Qourah, F ; Nikolaou, P E ; Femmino, S ; Tsoumani, M ; Varela, A ; Davos, C ; Dimitriou, C ; Kanaki, Z ; Dimitriadis, G ; Brizzi, M F ; Iliodromitis, E K ; Andreadou, I

Oxford University Press

Texto completo disponível

Effects of glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on vascular function and myocardial work index in patient with type-2 diabetes

Ikonomidis, I ; Pavlidis, G ; Thymis, J ; Birba, D ; Kalogeris, A ; Kousathana, F ; Kountouri, A ; Balampanis, K ; Parissis, J ; Andreadou, I ; Katogiannis, K ; Dimitriadis, G ; Bamias, A ; Iliodromitis, E ; Lambadiari, V

Texto completo disponível

Beta-amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease

Ikonomidis, I ; Katogiannis, K ; Kyriakou, E ; Taichert, M ; Katsimaglis, G ; Tsoumani, M ; Andreadou, I ; Lambadiari, V ; Maratou, I ; Kousathana, F ; Varlamos, C ; Plotas, P ; Alexopoulos, D ; Dimitriadis, G ; Tsantes, A.E

Texto completo disponível

Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes

Ikonomidis, I ; Pavlidis, G ; Thymis, J ; Birba, D ; Kalogeris, A ; Kousathana, F ; Kountouri, A ; Balampanis, K ; Parissis, J ; Andreadou, I ; Katogiannis, K ; Dimitriadis, G ; Bamias, A ; Iliodromitis, E ; Lambadiari, V

Texto completo disponível